Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Floxin Otic Solution for Acute Otitis Media in Children with Tympanostomy Tubes
NCT00781521Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of ofloxacin in acute otitis media (AOM), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Sponsor determined clinical cure of otitis media at 7 days and Sponsor determined microbiological cure of otitis media at 7 days. Started Nov 2002; status: completed.
02
Drugs
ofloxacin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00781521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781521.